搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
ophthalmologytimes
16 小时
Managing mental health in glaucoma
A large number of studies have focused on mental health declines associated with glaucoma. For example, about one-third of ...
ophthalmologytimes
1 天
Mount Sinai gifted $5 million for the center for ophthalmic artificial intelligence and ...
The Center, which was launched in 2023, will now be named The Barry Family Center for Ophthalmic Artificial Intelligence and ...
ophthalmologytimes
1 天
The impact of cross-linking on corneal transplant rates
Corneal cross-linking has led to a significant decline in corneal transplant rates for keratoconus globally. Cross-linking ...
ophthalmologytimes
2 天
AAO 2024: Centricity Vision to unveil new ZEPTOLink enhancements for improved efficiency ...
Centricity Vision announced new ZEPTOLink enhancements, reducing treatment time by up to 60%. These updates, aimed at ...
ophthalmologytimes
2 天
Oculis to present phase 3 DIAMOND program updates at Innovate Retina and Eyecelerator 2024
David Eichenbaum, MD and Riad Sherif, MD, CEO of Oculis will present the updates with additional info on topline results from ...
ophthalmologytimes
2 天
German Ophthalmological Society awards Theodor Leber Medal and honorary society memberships
The DOG recognised Heidelberg Engineering founder Christoph Schoess, Prof Herbert Kaufmann, and Prof Ioannis G. Pallikaris ...
ophthalmologytimes
2 天
Unlocking health mysteries
AD is a neurodegenerative disease characterized by neuronal loss in the cerebral cortex and the formation of extracellular ...
ophthalmologytimes
3 天
FDA approves Bausch + Lomb’s enVista Envy range of IOLs
According to the company, enVista Envy IOLs will be commercially available in the U.S. on a limited basis in the coming weeks ...
ophthalmologytimes
6 天
Innovation Series: AI’s impact on managing ocular surface disease with Peter J. McDonnell ...
Artificial intelligence has the potential to improve ophthalmology practices by streamlining documentation, enhancing ...
ophthalmologytimes
3 天
Anthony Wallace of Bausch + Lomb talks about enVista Envy FDA approval
The FDA granted approval to the enVista Envy full range of vision IOLs following Canadian approval in May 2024.
ophthalmologytimes
5 天
Paper: Rising diabetic retinopathy rates in youth signal potential public health crisis
A recent paper reveals increasing rates of diabetic retinopathy in young patients with diabetes, sparking concerns over ...
ophthalmologytimes
6 天
Melt Pharmaceuticals doses final patient in phase 3 trial of MELT-300
The phase 3 clinical trial is a randomized, double-blind, three-arm study comparing MELT-300, sublingual midazolam, and ...
当前正在显示可能无法访问的结果。
隐藏无法访问的结果
反馈